IP Verse

Combination Therapy For The Treatment Of Cancer

Patent No. EP3033086 (titled "Combination Therapy For The Treatment Of Cancer") was filed by Novartis on Aug 7, 2014. The application was issued on Sep 22, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BACHELINJun 22, 2022HOFFMANN EITLE
GENERICS UKJun 21, 2022ELKINGTON AND FIFE
HOFFMANN EITLEJun 21, 2022HOFFMANN EITLE
STADA ARZNEIMITTELJun 20, 2022HAMM & WITTKOPP
TEVA PHARMACEUTICALSJun 20, 2022D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3033086

NOVARTIS
Application Number
EP14752433A
Filing Date
Aug 7, 2014
Status
Granted And Under Opposition
Aug 20, 2021
Publication Date
Sep 22, 2021
External Links
Slate, Register , Google Patents